Precision medicine strongly relies on research models13,14 and cancer cell lines can represent widely accessible tools for the investigation and the functional characterization of therapeutically actionable KGF targets, paralleling the genetic alterations present in primary tumor samples11,15–19. The gene discussed is FGF7; the disease is neoplasm.